MedTrace Logo

Closed-loop Vasopressor Infusion Using Continuous Noninvasive Blood Pressure Monitoring

NCT04111055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-11-18

No results posted yet for this study

Summary

Intraoperative hypotension and blood pressure variability are associated with postoperative complications in surgical patients.

The investigators have developed a closed-loop vasopressor (CLV) controller that titrates norepinephrine to correct hypotension.

After having tested the system in a small cohort series of patients undergoing major surgeries, the investigators aimed to test the feasibility of the CLV controller guided noninvasively and continuously with the ClearSight system (Edwards Lifesciences, USA) in three high risk patients undergoing renal transplant surgery

Conditions

  • Hemodynamic (MAP) Stability

Interventions

DEVICE

Closed-loop system

the CLV system will correct hypotension by automated adjustment of norepinephrine.

Sponsors & Collaborators

Principal Investigators

  • Alexandre J Joosten, MD PhD · ERASME

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2018-07-20
Completion
2018-07-20

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111055 on ClinicalTrials.gov